CRISPR Therapeutics (CRSP) proposes to elect Briggs Morrison, M.D., to its Board of Directors at the Company’s annual general meeting to be ...

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for ...

Bohen will be AZ's executive vice president, global medicines development and chief medical officer, replacing Briggs Morrison, who left in June to become chief executive of private biotech Syndax.

Syndax is run by CEO Briggs Morrison, who was formerly head of medicines development at AstraZeneca for three years, before taking over at Syndax in 2015. Syndax CEO Briggs Morrison Morrison said ...

Previously serving as Briggs’ Chief Operating Officer, Leland brings more than 25 years of experience in the Industrial and Telecommunications industries to his new role. Since joining Briggs in ...

not the normal defence process looking at requirements and how you might solve it," says Briggs. "The prime minister of the day, Mr. Morrison, got it wrong. There was never a chance that it was ...